Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00029991 · ClinicalTrials.gov registry record · Phase 1
Extract of Ginkgo Biloba (EGB 761) and Vascular Function
A Phase 1 study, sponsored by National Center for Complementary and Integrative Health (NCCIH).
- Completed
- Registry status
- Phase 1
- Development phase
- 100
- Enrollment target
NCT00029991 is a Phase 1 study that has completed, run by National Center for Complementary and Integrative Health (NCCIH). The registered enrollment target is 100 participants.
The verdict
NCT00029991, a Phase 1 study, has completed, sponsored by National Center for Complementary and Integrative Health (NCCIH).
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 100 participants
- Enrollment target
Study Summary
This study will determine if a highly standardized herbal extract of the leaves of the Ginkgo Biloba tree will benefit patients who have pain on walking due to narrowing of the arteries of the legs.
Interventions
- DRUG Gingko Biloba (Herb)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2000-09 |
| Est. Completion | 2005-07 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00029991
The ClinicalTrials.gov registry entry for NCT00029991 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Center for Complementary and Integrative Health (NCCIH), which has 203 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Gingko Biloba (Herb) is the first listed.
NCT00029991 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00029991 about?
NCT00029991 is a clinical study titled "Extract of Ginkgo Biloba (EGB 761) and Vascular Function". This study will determine if a highly standardized herbal extract of the leaves of the Ginkgo Biloba tree will benefit patients who have pain on walking due to narrowing of the arteries of the legs.
What is the current status of trial NCT00029991?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 100 participants. The study started on 2000-09. Estimated completion is 2005-07.
What interventions are being tested in trial NCT00029991?
The interventions under investigation include: Gingko Biloba (Herb) (DRUG).
Who is sponsoring clinical trial NCT00029991?
This trial is sponsored by National Center for Complementary and Integrative Health (NCCIH), which has 203 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.